Art

J-GLOBAL ID：202002234228968152   Reference number：20A2441190

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

小児,思春期および若年成人癌の生存者のためのCOVID-19に関するガイダンス: 小児癌ガイドライングループの国際後期効果からの声明【JST・京大機械翻訳】

Author (48)： Verbruggen Lisanne C. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Wang Yuehan (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Armenian Saro H. (Department of Population Sciences, City of Hope National Medical Center, Duarte, California, USA) ,  Ehrhardt Matthew J. (Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Ehrhardt Matthew J. (Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  van der Pal Helena J.H. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  van Dalen Elvira C. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  van As Jorrit W. (Cochrane Childhood Cancer, Amsterdam, the Netherlands) ,  Bardi Edit (St Anna Childrens Hospital, Vienna, Austria) ,  Bardi Edit (Kepler University Clinic, Med Campus IV, Linz, Austria) ,  Baust Katja (Department for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany) ,  Berger Claire (Department for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France) ,  Berger Claire (Epidemiology of Childhood and Adolescent Cancers, CRESS, INSERM, UMR 1153, Paris Descartes University, Villejuif, France) ,  Castagnola Elio (Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Devine Katie A. (Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, New Jersey, USA) ,  Gebauer Judith (Institute for Endocrinology and Diabetes, University of Luebeck, Ratzeburger Allee 160, Luebeck, 23562, Germany) ,  Marchak Jordan Gilleland (Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA) ,  Glaser Adam W. (Department of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK) ,  Groll Andreas H. (Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children’s Hospital, Muenster, Germany) ,  Haeusler Gabrielle M. (NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia) ,  Haeusler Gabrielle M. (Department of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Children’s Hospital, Parkville, Victoria, Australia) ,  Haeusler Gabrielle M. (Murdoch Children’s Research Institute, Parkville, Victoria, Australia) ,  den Hartogh Jaap (Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, the Netherlands) ,  Haupt Riccardo (Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Hjorth Lars (Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden) ,  Kato Miho (Department of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children’s Medical Center, Okinawa, Japan) ,  Kepak Tomas (University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech Republic) ,  Koopman Maria M.W. (Rianne) (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Langer Thorsten (University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Ratzeburger Allee 160, Luebeck, 23562, Germany) ,  Maeda Miho (Department of Pediatrics, Nippon Medical School, Tokyo, Japan) ,  Michel Gisela (Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland) ,  Muraca Monica (Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Nathan Paul C. (The Hospital for Sick Children, Toronto, Canada) ,  van den Oever Selina R. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Pavasovic Vesna (Department of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK) ,  Sato Satomi (St. Luke’s International University, Tokyo, Japan) ,  Schulte Fiona (Department of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada) ,  Sung Lillian (Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada) ,  Tissing Wim (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Tissing Wim (Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands) ,  Uyttebroeck Anne (Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium) ,  Mulder Renee L. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Kuehni Claudia (Childhood Cancer Registry (ChCR), Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland) ,  Skinner Roderick (Department of Paediatric and Adolescent Haematology/Oncology, Great North Children’s Hospital, and Clinical and Translational Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK) ,  Hudson Melissa M. (Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Hudson Melissa M. (Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Kremer Leontien C.M. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Kremer Leontien C.M. (Amsterdam University Medical Center, Department of Pediatrics, Amsterdam, the Netherlands)
Material： Pediatric Blood & Cancer
Volume： 67  Issue： 12  Page： e28702  Publication year： 2020 
JST Material Number： W2716A  ISSN： 1545-5009  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Childhood, adolescent, and you...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2441190&from=J-GLOBAL&jstjournalNo=W2716A") }}

Thesaurus term： child ,  metabasis ,  *puberty (human) ,  *survivor ,  *Childhood cancer ,  *Young Adult ,  Cancer survivor

Author keywords (3)： childhood adolescent and young adult (CAYA) cancer survivors ,  COVID-19 ,  late effects of cancer treatment

JST classification (4)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical oncology in general  (GE03010Y)

Terms in the title (9)： 小児 ,  若年成人 ,  癌 ,  生存 ,  ガイダンス ,  小児癌 ,  ガイドライン ,  グループ ,  声明